immunity News and Research

RSS
Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

11 Mar 2022
Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

11 Mar 2022
Study shows vaccine effectiveness against SARS-CoV-2 and severe disease in dialysis patients

Study shows vaccine effectiveness against SARS-CoV-2 and severe disease in dialysis patients

10 Mar 2022
Long-lasting immune activity in the airways may be the cause of persistent post-COVID-19 breathlessness

Long-lasting immune activity in the airways may be the cause of persistent post-COVID-19 breathlessness

10 Mar 2022
Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

10 Mar 2022
Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

10 Mar 2022
Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

10 Mar 2022
Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

10 Mar 2022
The trajectory of B-cell immunity six months after mRNA vaccination

The trajectory of B-cell immunity six months after mRNA vaccination

10 Mar 2022
Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

9 Mar 2022
Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

9 Mar 2022
Pain neuron-derived peptide protects mice from endotoxic death by enhancing brain ATP production

Pain neuron-derived peptide protects mice from endotoxic death by enhancing brain ATP production

9 Mar 2022
Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

9 Mar 2022
Rabies transmission via vampire bats identified in Brazil

Rabies transmission via vampire bats identified in Brazil

9 Mar 2022
Study suggests recent common cold may actually lead to worse COVID-19 disease

Study suggests recent common cold may actually lead to worse COVID-19 disease

8 Mar 2022
Study identifies new immune checkpoint that may be exploited for cancer treatment

Study identifies new immune checkpoint that may be exploited for cancer treatment

8 Mar 2022
A promising approach for COVID-19 prophylaxis

A promising approach for COVID-19 prophylaxis

8 Mar 2022
Omicron-based vaccine candidate generated to assess whether immunogenicity could be further improved

Omicron-based vaccine candidate generated to assess whether immunogenicity could be further improved

8 Mar 2022
Current and future perspectives of mRNA technology

Current and future perspectives of mRNA technology

8 Mar 2022
Comparative immunogenicity of reduced and standard BNT162b2 and mRNA-1273 boosters in CoronaVac vaccinees

Comparative immunogenicity of reduced and standard BNT162b2 and mRNA-1273 boosters in CoronaVac vaccinees

8 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback